1. Home
  2. STXS vs SCWO Comparison

STXS vs SCWO Comparison

Compare STXS & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • SCWO
  • Stock Information
  • Founded
  • STXS 1990
  • SCWO 2021
  • Country
  • STXS United States
  • SCWO United States
  • Employees
  • STXS N/A
  • SCWO N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SCWO Environmental Services
  • Sector
  • STXS Health Care
  • SCWO Utilities
  • Exchange
  • STXS Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • STXS 151.3M
  • SCWO 56.4M
  • IPO Year
  • STXS 2004
  • SCWO N/A
  • Fundamental
  • Price
  • STXS $2.16
  • SCWO $0.19
  • Analyst Decision
  • STXS
  • SCWO
  • Analyst Count
  • STXS 0
  • SCWO 0
  • Target Price
  • STXS N/A
  • SCWO N/A
  • AVG Volume (30 Days)
  • STXS 286.3K
  • SCWO 1.2M
  • Earning Date
  • STXS 08-11-2025
  • SCWO 08-13-2025
  • Dividend Yield
  • STXS N/A
  • SCWO N/A
  • EPS Growth
  • STXS N/A
  • SCWO N/A
  • EPS
  • STXS N/A
  • SCWO N/A
  • Revenue
  • STXS $27,510,000.00
  • SCWO $673,267.00
  • Revenue This Year
  • STXS $25.90
  • SCWO $5,945.19
  • Revenue Next Year
  • STXS $60.57
  • SCWO $106.82
  • P/E Ratio
  • STXS N/A
  • SCWO N/A
  • Revenue Growth
  • STXS 1.50
  • SCWO 161.19
  • 52 Week Low
  • STXS $1.54
  • SCWO $0.16
  • 52 Week High
  • STXS $2.72
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • STXS 49.74
  • SCWO 31.52
  • Support Level
  • STXS $2.08
  • SCWO $0.35
  • Resistance Level
  • STXS $2.36
  • SCWO $0.44
  • Average True Range (ATR)
  • STXS 0.13
  • SCWO 0.06
  • MACD
  • STXS -0.01
  • SCWO -0.02
  • Stochastic Oscillator
  • STXS 44.44
  • SCWO 9.09

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: